#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous T-cell lymphoma Follicle centre lymphoma follicular grade I, II – III Haemophilia A with anti factor VIII Iron overload HER2 mutant non-small cell lung cancer Acute respiratory distress syndrome Fatty acid oxidation disorder Thalassaemia alpha Systemic candida Hypochondroplasia Paraneoplastic neurological syndrome Behcet's syndrome Chondrodystrophy Eosinophilic granulomatosis with polyangiitis Cardiac failure acute More trials…

    Learn about Rare Diseases

    Wolfram syndrome – Basic Information Congenital nephrogenic diabetes insipidus – Diagnostics Rhabdomyosarcoma recurrent – Diagnostics Shprintzen-Goldberg syndrome – Diagnostics Inclusion body myositis – Trials in Disease Waldenstrom’s macroglobulinaemia – Diagnostics Alagille syndrome – Diagnostics Pituitary-dependent Cushing’s syndrome – Life with Disease Testicular leiomyosarcoma SAPHO syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Triheptanoin Thiotepa CICLOPIROX ARFOLITIXORIN Calcitriol Sargramostim Saline Remestemcel TEDUGLUTIDE Clindamycin Hydrochloride Rly-4008 Ep0042 Oxcarbazepine Brodalumab Belzupacap Sarotalocan Jk06 Belatacept Gs-5245 Lutetium (177Lu) Oxodotreotide Water For Injections More therapies…

    Learn about Your Condition

    Penile squamous cell carcinoma Essential thrombocythaemia Pain Perineal injury Liver transplant rejection Cortisol abnormal Prinzmetal angina Traumatic pain Cutibacterium acnes infection Left ventricular dysfunction Osteoporosis Immune-mediated renal disorder Albuminuria Tonsillitis Stomatitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Axial spondyloarthritis

  • A study testing SPY072 compared to placebo in adults with moderately to severely active rheumatologic disease

    Not recruiting

    2 1
    Bulgaria Czechia Poland Spain

  • Study on the Effects of Risankizumab in Patients with Very Early Axial Spondyloarthritis

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    Investigated Drugs:
    • Risankizumab
    Germany

  • Study on the Effects of Sonelokimab for Patients with Active Axial Spondyloarthritis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    Investigated Drugs:
    • Sonelokimab
    Germany

  • Study on Ixekizumab for Rapid Pain Relief in Patients with Axial Spondyloarthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    Investigated Drugs:
    • Ixekizumab
    Germany

  • Study of Secukinumab for Maintaining Remission in Patients with Non-Radiographic Axial Spondyloarthritis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Secukinumab
    Belgium Czechia France Germany Hungary Italy +3

  • Study on Tofacitinib for Patients with Early Active Axial Spondyloarthritis Who Did Not Respond to NSAIDs

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    Investigated Drugs:
    • Naproxen
    • Tofacitinib
    Bulgaria Czechia Germany Poland
Previous Page
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!